Cargando…

Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review

Close connections between depression and type 2 diabetes (T2DM) have been suggested by many epidemiological and experimental studies. Disturbances in insulin sensitivity due to the disruption of various molecular pathways cause insulin resistance, which underpins many metabolic disorders, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Young Sup, Lim, Hyun Kook, Wang, Sheng-Min, Bahk, Won-Myong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554794/ https://www.ncbi.nlm.nih.gov/pubmed/32971941 http://dx.doi.org/10.3390/ijms21186969

Ejemplares similares

Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2016)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review
por: Choi, Won-Seok, et al.
Publicado: (2022)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2021)

Patient Factors Influencing Outpatient Retention in Patients with Affective and Anxiety Disorders: A Retrospective Study
por: Chang, Seyeon, et al.
Publicado: (2021)

The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
por: Lee, Jung Goo, et al.
Publicado: (2019)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

PS150. Comparative efficacy of various augmentation strategies for treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

A Practical Utility and Benefit of Pharmacogenetic-based Antidepressant Treatment Strategy for Major Depressive Disorder Patients with Difficult-to-treat
por: Lee, Kyung Ho, et al.
Publicado: (2021)

Erratum: Lee, J.G., et al. The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease. Brain Sciences 2019, 9(10), 285
por: Lee, Jung Goo, et al.
Publicado: (2019)

Relationship between Delusion of Theft and Cognitive Functions in Patients with Mild Alzheimer’s Disease
por: Na, Hae-Ran, et al.
Publicado: (2018)

The Impact of COVID-19 on Psychiatric Health in the Korean Population
por: Wang, Sheng-Min, et al.
Publicado: (2023)

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients
por: Woo, Young Sup, et al.
Publicado: (2016)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Pathophysiology of Depression: Stingless Bee Honey Promising as an Antidepressant
por: Zakaria, Fatin Haniza, et al.
Publicado: (2022)

Diagnostic Validity of an Automated Probabilistic Tractography in Amnestic Mild Cognitive Impairment
por: Jung, Won Sang, et al.
Publicado: (2018)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Ginkgo biloba induced mood dysregulation: a case report
por: Rho, Seung Sun, et al.
Publicado: (2018)

Naltrexone-associated Visual Hallucinations: A Case Report
por: Lee, Dae Bo, et al.
Publicado: (2019)

A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2018)

Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial
por: Han, Changsu, et al.
Publicado: (2020)

The Usefulness and Clinical Characteristics of Antidepressant Use for Stroke Patients with Rehabilitation Program: An Exploratory Analysis
por: Lee, Kyung Ho, et al.
Publicado: (2020)

Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
por: Hermansen, Kjeld, et al.
Publicado: (2008)

A Comparative Study on the Predictive Value of Different Resting-State Functional Magnetic Resonance Imaging Parameters in Preclinical Alzheimer's Disease
por: Wang, Sheng-Min, et al.
Publicado: (2021)

Predictors of a Shorter Time to Hospitalization in Patients with Bipolar Disorder: Medication during the Acute and Maintenance Phases and Other Clinical Factors
por: Shim, In Hee, et al.
Publicado: (2017)

Rapid Non-Enzymatic Glycation of the Insulin Receptor under Hyperglycemic Conditions Inhibits Insulin Binding In Vitro: Implications for Insulin Resistance
por: Rhinesmith, Tyler, et al.
Publicado: (2017)

Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients
por: Lim, Yejee, et al.
Publicado: (2022)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang, Hee Ryung, et al.
Publicado: (2015)

The Brain–Gut–Microbiome Axis in Psychiatry
por: Jang, Seung-Ho, et al.
Publicado: (2020)

Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Woo, Young Sup, et al.
Publicado: (2022)

Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies
por: Cao, Thao T. B., et al.
Publicado: (2020)

Antidepressant Effects on Insulin Sensitivity and Proinflammatory Cytokines in the Depressed Males
por: Chen, Yi-Chyan, et al.
Publicado: (2010)

Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
por: Jeong, Jong-Hyun, et al.
Publicado: (2013)

Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin
por: Panahi, Yunes, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4dkbhm28gngnredjjjag36g438